|
Address:
|
12544 HIGH BLUFF DRIVE
SUITE 200
|
|
City:
|
SAN DIEGO
|
|
State:
|
CA
|
|
Zip Code:
|
92130
|
|
Telephone:
|
858-552-1100
|
Description of Business
|
Primary SIC Code:
2835
|
|
(As filed with the SEC)
|
|
|
All references to "we," "our," and "us" in this Annual Report refer to Quidel
Corporation and its subsidiaries.
Overview
We have a leadership position in the development, manufacturing and marketing of
rapid diagnostic testing solutions. These diagnostic testing solutions are
separated into our four product categories: rapid immunoassays, cardiac
immunoassays, specialized diagnostic solutions and molecular diagnostic
solutions. We sell our products directly to end users and distributors, in each
case, for professional use in physician offices, hospitals, clinical
laboratories, reference laboratories, leading universities, retail clinics,
pharmacies and wellness screening centers. We market our products through a
network of distributors, and through a direct sales force. The Company operates
in one business segment that develops, manufactures and markets our four product
categories. ... More ...
|
|
Date
|
12-mos Rolling EPS
|
Dividend
|
P/E Ratio
|
| 12/2017 | -0.24 | NA | N/E | | 09/2017 | 0.15 | NA | 292.40 | | 06/2017 | 0.00 | NA | N/E | | 03/2017 | 0.11 | NA | 205.82 | | 12/2016 | -0.42 | NA | N/E | | 09/2016 | -0.37 | NA | N/E | | 06/2016 | -0.39 | NA | N/E | | 03/2016 | -0.40 | NA | N/E |
Key Financial Ratios and Statistics
|
FYE:
12/31
|
|
Profitability
|
2017
|
Leverage
|
2017
|
| Net Inc/Comm Equity | -0.03 | Total Liab/Total Assets | 0.76 | | Net Inc/Total Assets | -0.01 | Total Liab/Inv Cap | 0.90 | | Net Inc/Inv Cap | -0.01 | Total Liab/Comm Equity | 2.96 | | Pretax Inc/Net Sales | -0.03 | Interest Coverage Ratio | 0.54 | | Net Inc/Net Sales | -0.03 | Curr Debt/Equity | 0.09 | | Cash Flow/Net Sales | 0.10 | LTD/Equity | 1.66 | | SG&A/NetSales | 0.35 | Total Debt/Equity | 1.75 |
|
Asset Utilization
|
|
Liquidity
|
|
| Net Receivables Turnover | 6.04 | Quick Ratio | 2.06 | | Inventory Turnover | 2.61 | Current Ratio | 2.58 | | Inventory Day Sales | 0.00 | Net Rec/Curr Assets | 0.20 | | Net Sales/Work Cap | 1.37 | Inv/Curr Assets | 0.20 | | Net Sales/PP&E | 4.51 | | |
Income Statement (Millions)
|
| |
12/31/2017
|
9/30/2017
|
6/30/2017
|
3/31/2017
|
|
Total Revenues(Net Sales)
|
114.89
|
50.89
|
38.27
|
73.69
|
|
Cost of Goods Sold
|
60.89
|
19.39
|
17.76
|
23.57
|
|
Selling & Admin Exps
|
37.14
|
19.48
|
19.09
|
20.73
|
|
Operating Income
|
3.89
|
-2.54
|
-11.03
|
19.23
|
|
Interest Exp
|
9.20
|
2.78
|
2.78
|
2.83
|
|
Pretax Income
|
-5.31
|
-5.32
|
-13.81
|
16.40
|
|
Other Income
|
NA
|
NA
|
NA
|
NA
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-5.09
|
-5.53
|
-11.84
|
14.29
|
|
Assets
|
12/31/2017
|
9/30/2017
|
6/30/2017
|
3/31/2017
|
|
Cash & Short Term Investments
|
36.09
|
172.99
|
175.05
|
197.49
|
|
Receivables - Total
|
67.05
|
41.58
|
19.84
|
20.94
|
|
Inventories - Total
|
67.08
|
23.43
|
22.96
|
22.47
|
|
Total Current Assets
|
331.23
|
244.48
|
225.25
|
244.95
|
|
Net Property, Plant & Equipment
|
61.59
|
50.04
|
51.02
|
49.88
|
|
Total Assets
|
935.25
|
413.82
|
398.54
|
404.50
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
43.21
|
25.43
|
20.64
|
17.69
|
|
Debt in Current Liabilities
|
20.18
|
0.12
|
0.11
|
0.11
|
|
Total Current Liabilities
|
128.35
|
38.94
|
31.33
|
29.13
|
|
Long-Term Debt
|
377.26
|
152.35
|
151.00
|
149.66
|
|
Total Liabilities
|
708.15
|
194.94
|
185.95
|
184.38
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Common Stock
|
0.04
|
0.03
|
0.03
|
0.03
|
|
Retained Earnings
|
-12.42
|
-7.33
|
-1.81
|
10.04
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
227.10
|
218.88
|
212.59
|
220.12
|
|
Total Liabilities and Stockholders' Equity
|
935.25
|
413.82
|
398.54
|
404.50
|
Cash Flow Summary (Millions)
|
|
Categories
|
12/31/2017
|
9/30/2017
|
6/30/2017
|
3/31/2017
|
|
Net Cash Provided by Operating Activities
|
11.23
|
-7.52
|
-5.57
|
29.58
|
|
Net Cash Provided by Investing Activities
|
-404.60
|
-4.43
|
-19.01
|
-3.71
|
|
Net Cash Provided by Financing Activities
|
256.47
|
9.89
|
2.13
|
2.12
|
Annual Summary Data (Millions)
|
|
Year
|
Sales
|
Net Income
|
EPS
|
| 12/2013 | 177.32 | 7.39 | 0.21 | | 12/2014 | 184.16 | -7.07 | -0.21 | | 12/2015 | 196.13 | -6.08 | -0.18 | | 12/2016 | 191.60 | -13.81 | -0.42 | | 12/2017 | 277.74 | -8.16 | -0.24 | | Growth Rates | 11.87 | -- | -- |
|
Type
|
Date(Q,M)
|
No. Owners
|
Shares Held (000s)
|
% Own
|
| Institutional | 03/31/18 | 153 | 32,590 | 87.42 |
|
Report Date :
4/16/2018
 ©
2018EDGAR®Online,
a division of Donnelley Financial Solutions. EDGAR® is a federally registered
trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated
with or approved by the U.S. Securities and Exchange Commission.
|
|